Biora Therapeutics, Inc. (BIORQ) Financials
Stock symbol BIORQ is outdated, potentially delisted? Maybe it is available on other exchange?
BIORQ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 14.5 million | 121.1 million |
| June 30, 2024 | 18.3 million | 107.6 million |
| March 31, 2024 | 23.0 million | 123.2 million |
| Dec. 31, 2023 | 31.2 million | 132.6 million |
BIORQ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | 32.0 million | -62000 |
| June 30, 2024 | -11.1 million | 1.6 million |
| March 31, 2024 | -12.5 million | 1.5 million |
| Dec. 31, 2023 | -13.8 million | 1.5 million |
BIORQ Net Income
No data available :(
BIORQ Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 3.2 million | 14.3 million | 1.1 million |
| June 30, 2024 | 5.3 million | 43.8 million | 1.3 million |
| March 31, 2024 | 10.8 million | 43.3 million | 1.5 million |
| Dec. 31, 2023 | 15.2 million | 43.7 million | 1.7 million |
BIORQ Shares Outstanding
BIORQ Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | 19000 | 5.6 million | 10.6 million | - |
| June 30, 2024 | 180000 | 7.7 million | 8.4 million | - |
| March 31, 2024 | 15000 | 7.0 million | 9.1 million | 1.2 million |
| Dec. 31, 2023 | 66000 | 6.1 million | 7.1 million | -1.2 million |
BIORQ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | 32000 | - |
| June 30, 2024 | 318000 | 110000 |
| March 31, 2024 | 542000 | 117000 |
| Dec. 31, 2023 | 872000 | 117000 |
BIORQ Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BIORQ
Price: $0
52 week price:
Earnings Per Share: 0.36 USD
P/E Ratio: 0.61
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 994994